Martín Rosas-Peralta

La obesidad y el síndrome metabólico como problema de salud pública: una reflexión

* Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.** Comision Coordinadora de Institutos Nacionales de Salud y Hospitales de Alta Especialidad.*** Instituto Nacional de Pediatria.**** Instituto Nacional de Salud Publica.***** Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz.****** Instituto Nacional de Medicina Genomica.******* Instituto Nacional de Cardiologia Ignacio Chavez.******** Hospital General Dr. Manuel Gea Gonzalez.

Efectos inmunometabólicos disfuncionales de la deficiencia de vitamina D y aumento de riesgo cardiometabólico. ¿Potencial alerta epidemiológica en América?

Vitamin D deficiency is a serious public health problem worldwide that affects not only skeletal health, but also a wide range of acute and chronic diseases. However, there is still skepticism because of the lack of randomized, controlled trials to support association studies on the benefits of vitamin D for non-skeletal health. This review was based on articles published during the 1980-2015 obtained from the Cochrane Central Register of controlled trials, MEDLINE and PubMed, and focuses on recent challenges with regard to the definition of vitamin D deficiency and how to achieve optimal serum 25-hydroxyvitamin D levels from dietary sources, supplements, and sun exposure. The effect of vitamin D on epigenetic fetal programming and regulation of genes that may potentially explain why vitamin D could have such lifelong comprehensive health benefits is reviewed. Optimization of vitamin D levels in children and adults around the world has potential benefits to improve skeletal health and to reduce the risk of chronic diseases, including some types of cancer, autoimmune diseases, infectious diseases, type 2 diabetes mellitus, and severe cardiovascular disorders such as atherothrombosis, neurocognitive disorders, and mortality.